Comerica Bank’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $147K | Sell |
23,922
-5,048
| -17% | -$36.6K | ﹤0.01% | 2456 |
|
|
2025
Q3 | $209K | Sell |
28,970
-3,249
| -10% | -$19.3K | ﹤0.01% | 2306 |
|
|
2025
Q2 | $171K | Sell |
32,219
-423
| -1% | -$2.5K | ﹤0.01% | 2385 |
|
|
2025
Q1 | $290K | Sell |
32,642
-105
| -0.3% | -$1.26K | ﹤0.01% | 2129 |
|
|
2024
Q4 | $449K | Sell |
32,747
-2,525
| -7% | -$46.6K | ﹤0.01% | 1924 |
|
|
2024
Q3 | $966K | Sell |
35,272
-36,062
| -51% | -$976K | ﹤0.01% | 1560 |
|
|
2024
Q2 | $1.74M | Sell |
71,334
-8,649
| -11% | -$190K | 0.01% | 1186 |
|
|
2024
Q1 | $1.71M | Sell |
79,983
-2,855
| -3% | -$61.4K | 0.01% | 1261 |
|
|
2023
Q4 | $1.59M | Buy |
82,838
+2,143
| +3% | +$37.1K | 0.01% | 1292 |
|
|
2023
Q3 | $1.29M | Sell |
80,695
-16,143
| -17% | -$307K | 0.01% | 1298 |
|
|
2023
Q2 | $3 | Buy |
+96,838
| New | +$2.11M | ﹤0.01% | 536 |
|
|
2022
Q4 | $1.64M | Sell |
88,269
-13,515
| -13% | -$252K | 0.01% | 1194 |
|
|
2022
Q3 | $1.92M | Sell |
101,784
-6,625
| -6% | -$152K | 0.02% | 1062 |
|
|
2022
Q2 | $2.47M | Buy |
108,409
+2,590
| +2% | +$53.8K | 0.02% | 964 |
|
|
2022
Q1 | $2.43M | Sell |
105,819
-1,145
| -1% | -$29.3K | 0.02% | 1043 |
|
|
2021
Q4 | $2.78M | Sell |
106,964
-3,834
| -3% | -$111K | 0.02% | 921 |
|
|
2021
Q3 | $3.6M | Sell |
110,798
-1,701
| -2% | -$56.5K | 0.02% | 888 |
|
|
2021
Q2 | $3.81M | Sell |
112,499
-3,720
| -3% | -$107K | 0.02% | 868 |
|
|
2021
Q1 | $3.5M | Sell |
116,219
-3,002
| -3% | -$85.2K | 0.02% | 981 |
|
|
2020
Q4 | $3.17M | Buy |
119,221
+557
| +0.5% | +$8.99K | 0.02% | 1001 |
|
|
2020
Q3 | $1.73M | Sell |
118,664
-225
| -0.2% | -$2.85K | 0.01% | 1232 |
|
|
2020
Q2 | $1.42M | Buy |
118,889
+6,149
| +5% | +$87.3K | 0.01% | 1301 |
|
|
2020
Q1 | $1.64M | Buy |
112,740
+2,545
| +2% | +$53.8K | 0.02% | 1047 |
|
|
2019
Q4 | $3.12M | Buy |
110,195
+515
| +0.5% | +$14.2K | 0.02% | 821 |
|
|
2019
Q3 | $3.58M | Buy |
109,680
+463
| +0.4% | +$13.5K | 0.03% | 691 |
|
|
2019
Q2 | $2.87M | Sell |
109,217
-3,652
| -3% | -$103K | 0.02% | 842 |
|
|
2019
Q1 | $3.76M | Sell |
112,869
-5,684
| -5% | -$173K | 0.03% | 687 |
|
|
2018
Q4 | $3.27M | Buy |
118,553
+5,614
| +5% | +$202K | 0.03% | 755 |
|
|
2018
Q3 | $4.89M | Sell |
112,939
-5,376
| -5% | -$239K | 0.04% | 517 |
|
|
2018
Q2 | $5.07M | Sell |
118,315
-2,929
| -2% | -$98.9K | 0.04% | 612 |
|
|
2018
Q1 | $3.52M | Buy |
121,244
+2,153
| +2% | +$72.8K | 0.03% | 862 |
|
|
2017
Q4 | $4.81M | Sell |
119,091
-1,026
| -0.9% | -$34.6K | 0.03% | 688 |
|
|
2017
Q3 | $4.14M | Buy |
120,117
+1,029
| +0.9% | +$29.4K | 0.03% | 726 |
|
|
2017
Q2 | $2.88M | Sell |
119,088
-4,097
| -3% | -$87K | 0.02% | 947 |
|
|
2017
Q1 | $2.26M | Buy |
123,185
+71,435
| +138% | +$1.27M | 0.02% | 1141 |
|
|
2016
Q4 | $845K | Buy |
51,750
+2,348
| +5% | +$42.5K | 0.01% | 1661 |
|
|
2016
Q3 | $1.05M | Buy |
49,402
+151
| +0.3% | +$3.83K | 0.01% | 1467 |
|
|
2016
Q2 | $1.45M | Hold |
49,251
| – | – | 0.01% | 1270 |
|
|
2016
Q1 | $1.92M | Buy |
49,251
+328
| +0.7% | +$12.4K | 0.02% | 1055 |
|
|
2015
Q4 | $2.07M | Sell |
48,923
-2
| -0% | -$84 | 0.02% | 948 |
|
|
2015
Q3 | $1.83M | Sell |
48,925
-49,147
| -50% | -$1.74M | 0.02% | 1070 |
|
|
2015
Q2 | $3.33M | Buy |
98,072
+49,002
| +100% | +$1.67M | 0.01% | 1206 |
|
|
2015
Q1 | $1.74M | Sell |
49,070
-49,266
| -50% | -$1.76M | 0.01% | 1173 |
|
|
2014
Q4 | $3.35M | Buy |
98,336
+48,799
| +99% | +$1.73M | 0.01% | 1172 |
|
|
2014
Q3 | $1.91M | Sell |
49,537
-917
| -2% | -$34.2K | 0.02% | 1085 |
|
|
2014
Q2 | $1.96M | Sell |
50,454
-6,129
| -11% | -$228K | 0.02% | 1108 |
|
|
2014
Q1 | $1.94M | Sell |
56,583
-900
| -2% | -$27.9K | 0.01% | 1155 |
|
|
2013
Q4 | $1.21M | Sell |
57,483
-17,044
| -23% | -$431K | 0.01% | 1445 |
|
|
2013
Q3 | $1.75M | Buy |
74,527
+11,393
| +18% | +$324K | 0.01% | 1232 |
|
|
2013
Q2 | $1.7M | Buy |
+63,134
| New | +$1.83M | 0.01% | 1057 |
|
Other funds holding MYGN
GCM
Comerica Bank's MYGN Position: Q4 2025 in Review
Comerica Bank reduced its Myriad Genetics (MYGN) stake by 17% in Q4 2025, selling an estimated $36.6K and leaving 23,922 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #2456.
Comerica Bank first reported a position in MYGN in Q2 2013 and has held it in 50 quarters since. The position peaked at $5.07M in Q2 2018. 221 funds tracked by Wall St. Rank hold MYGN as of Q4 2025.
- Comerica Bank held 23,922 shares of Myriad Genetics worth $147K as of Q4 2025.
- Comerica Bank sold 5,048 Myriad Genetics shares in Q4 2025, an estimated $36.6K.
- Myriad Genetics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2456 holding.
- Comerica Bank first reported a position in Myriad Genetics in Q2 2013 and has held it in 50 quarters since.
- Comerica Bank's Myriad Genetics position peaked at $5.07M in Q2 2018.
- 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2025.
Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.